Procter & Gamble Hygiene and Health Care Ltd (PGHH) — shareholding pattern, promoter holding, financials and share price
About Procter & Gamble Hygiene and Health Care Ltd (PGHH)
Procter & Gamble Hygiene and Health Care Ltd operates in the Personal Care industry, within the Fast Moving Consumer Goods sector. It trades on the NSE as PGHH and on the BSE under scrip code 500459. Its ISIN is INE179A01014.
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.
Procter & Gamble Hygiene and Health Care Limited manufactures and sells fast-moving consumer goods, focusing on feminine and healthcare products. Their portfolio includes phenomenally popular brands like Whisper in feminine care and Vicks in health care.
In FY 2024-25, P&G achieved balanced growth, with strong top- and bottom-line performance despite a shortened 9-month fiscal year.
Listed peers in Personal Care: Colgate-Palmolive (India) Ltd, Cupid Ltd, Gillette India Ltd, Emami Ltd, Honasa Consumer Ltd, Bajaj Consumer Care Ltd.
Valuation & Returns
10 Jul 2026At ₹8,951.15 a share on 10 Jul 2026, Procter & Gamble Hygiene and Health Care Ltd (PGHH) was valued at a price-to-earnings ratio of 33.92x against an industry P/E of 46.1x and a price-to-book of 39.43x on a book value of ₹227.04 per share as of Mar 2025. Solomo computes return on equity of 116.22% and return on capital employed of 159.08% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 33.92x
- Industry P/E
- 46.1x
- P/B
- 39.43x
- EPS (TTM)
- ₹263.86
- Book value / share
- ₹227.04
- ROE
- 116.22%
- ROCE
- 159.08%
- ROA
- 48.81%
- Debt / equity
- 0x
- Dividend yield
- 2.63%
- EBITDA margin
- 28.34%
- 52-week range
- ₹8,739.7 – ₹14,536.6
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Procter & Gamble Hygiene and Health Care Ltd (PGHH) reported revenue of ₹4,290 crore, net profit of ₹856 crore and earnings per share of ₹263.86. That compares with revenue of ₹3,374 crore and net profit of ₹637 crore in Mar 2025 9m. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹941 crore and net profit ₹153 crore (standalone).
| Metric | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2025 9m | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 3,918 | 4,206 | 3,374.42 | 3,374 | 4,290 |
| Net profit (₹ cr) | 678 | 675 | 636.59 | 637 | 856 |
| EPS (₹) | 208.91 | 207.95 | 221.08 | 196.11 | 263.86 |
| Measure | 1Y |
|---|---|
| Sales growth | -19.77% |
| Profit growth | -5.69% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 70.64% of Procter & Gamble Hygiene and Health Care Ltd (PGHH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.98% and domestic institutional investors (DII) hold 15.59%. Market capitalisation was ₹29,056 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: SBI Focused Fund 5.06%, Life Insurance Corporation of India 4.07%, General Insurance Corporation of India 2.06%, ICICI Prudential Large Cap Fund 1.56%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 70.64% | - | 0.98% | 15.59% | 29.36% |
| Mar 2026 | 70.64% | - | 0.97% | 15.97% | 29.36% |
| Dec 2025 | 70.64% | - | 1.07% | 16.04% | 29.36% |
| Sep 2025 | 70.64% | - | 1.11% | 16.06% | 29.36% |
| Jun 2025 | 70.64% | - | 1.38% | 15.49% | 29.36% |
| Mar 2025 | 70.64% | - | 1.33% | 15.51% | 29.36% |
| Dec 2024 | 70.64% | - | 1.43% | 15.37% | 29.36% |
| Sep 2024 | 70.64% | - | 1.48% | 15.28% | 29.36% |